Navigation Links
Joslin researcher named first winner of the Manpei Suzuki International Prize for Diabetes Research
Date:11/6/2008

BOSTON November 6, 2008 Joslin Diabetes Center today announced that C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research.

"Joslin Diabetes Center is delighted that one of our world-renowned researchers has been named the inaugural winner of such a prestigious award," said Ranch C. Kimball, President and CEO of Joslin. "Dr. Kahn epitomizes the spirit, perseverance and creativity held by all Joslin researchers that is needed to make the scientific advancements toward preventing and ultimately curing diabetes."

According to the Manpei Suzuki Diabetes Foundation, Dr. Kahn was selected to receive the inaugural award in recognition of his many contributions to diabetes research over the past three decades from the discovery of the basic mechanism for how insulin receptors produce a signal in cells to increase their metabolism, to alterations in this signaling process in diabetes and other disease states. He has also generated multiple strains of mice genetically altered in insulin signaling in order to analyze insulin action one tissue and pathway at a time. Dr. Kahn's work has had an enormous impact on the understanding of the mechanism of insulin action and insulin resistance, processes that are fundamental to the worldwide diabetes epidemic.

"I am truly honored to be recognized for this prize as my lab and I to continue to pursue new frontiers in diabetes and obesity research," said Dr. Kahn.

Dr. Kahn will be formally presented with the award, which includes $150,000, at a ceremony in Tokyo on March 10, 2009. He will also deliver a commemorative lecture at the event.

The newly established award, the largest for diabetes research and one of the largest in medicine, commemorates the 15th anniversary of the Manpei Suzuki Diabetes Foundation, which supports diabetes research through both grants and fellowships. According to the Foundation's web site, the International Prize acknowledges individuals for "their original and excellent achievements in diabetes research" and aims "to advance diabetes research that will contribute to the health and welfare of all people."

An internationally recognized researcher, Dr. Kahn was educated at University of Louisville and trained at Washington University and the National Institutes of Health, where he ultimately served as the Section Head of Cellular and Molecular Physiology of the Diabetes Branch.

In 1981, Dr. Kahn came to Harvard Medical School and the Joslin Diabetes Center. He served as Research Director of Joslin from 1981 to 2000, Executive Vice President from 1997 to 2000, and President and Director from 2000 to 2007. In 1984, he was promoted to Professor of Medicine at Harvard, and in 1986 he was awarded the Mary K. Iacocca Professorship. In 2007, he was named Vice Chair of the Joslin Board of Trustees.

Dr. Kahn has received the highest scientific awards of the American Diabetes Association, U.S. Endocrine Society, British Diabetes and Endocrine Societies, Juvenile Diabetes Research Foundation, International Diabetes Federation and American Federation for Clinical Research, as well as many other honors, including election to the National Academy of Sciences and the Institute of Medicine. He chaired the congressionally established Diabetes Research Working Group which developed the plan that resulted in a more than doubling of diabetes research efforts in the U.S. He also holds honorary doctorates from the Universities of Paris, Louisville and Geneva and an honorary professorship from Peking University.


'/>"/>

Contact: Kira Jastive
kira.jastive@joslin.harvard.edu
617-732-2418
Joslin Diabetes Center
Source:Eurekalert

Related medicine news :

1. Joslin study finds restricting insulin doses increases mortality risk
2. Researchers describe how chronic inflammation can lead to stomach cancer
3. Researchers ID Genetic Markers for Esophageal Cancer
4. Opt out system could solve donor organ shortage, says researcher
5. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
6. Cancer requires support from immune system to develop, UT Southwestern researchers report
7. Researchers find new chemical key that could unlock hundreds of new antibiotics
8. Penn researchers find key to Sonic hedgehog control of brain development
9. Temple researchers look for behavioral link between breastfeeding and lower risk of obesity
10. MU researchers advance health communication for at-risk populations
11. Researcher to provide new insight for treating vascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: